SCHEMBL16628837

SCHEMBL16628837

COCCCNC(=O)c1nc(N)nc2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 5/20 0.58
KDM4E B2RXH2 3/20 0.56
TP53 P04637 3/20 0.56
GLA P06280 2/20 0.56
ALDH1A1 P00352 2/20 0.56
GAA P10253 1/20 0.56
HPGD P15428 1/20 0.56
CASP1 P29466 1/20 0.56
CASP7 P55210 1/20 0.56
HSD17B10 Q99714 1/20 0.56
MAPT P10636 1/20 0.54
ATM Q13315 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
ADORA2A P29274 3/20 0.53
ADORA1 P30542 2/20 0.53
ADORA2B P29275 1/20 0.53
POLB P06746 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
LMNA P02545 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3096053 0.88 ADORA3 (0.59) ADORA3ADORA2AADORA1ADORA2BSMN1; SMN2
SCHEMBL3094118 0.87 ADORA3 (0.58) ADORA3KDM4EGLAALDH1A1GAA
SCHEMBL3087918 0.85 ADORA3 (0.62) ADORA3KDM4EALDH1A1GAAHPGD
SCHEMBL16628741 0.85 HTT (0.61) ADORA3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL3093862 0.85 ADORA2A (0.62) ADORA3KDM4EALDH1A1ADORA2AADORA1
SCHEMBL3081056 0.83 ADORA2A (0.70) ADORA3ALDH1A1MAPTADORA2AADORA1
SCHEMBL3093664 0.82 ADORA3 (0.55) ADORA3KDM4ETP53GLAALDH1A1
SCHEMBL3087861 0.82 ADORA3 (0.65) ADORA3ALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL16628820 0.82 ADORA3 (0.68) ADORA3KDM4ETP53ALDH1A1GAA
SCHEMBL3081770 0.82 ADORA3 (0.58) ADORA3KDM4ETP53GLAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP claimed